Palantir (NASDAQ:PLTR) stock was one of last year’s biggest winners and with the way 2025 is shaping up to be, don’t bet ...
We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...
We recently compiled a list of the Billionaire Ken Fisher’s Top 10 High Growth Stock Picks. In this article, we are going to ...
Big data analytics company Palantir Technologies (PLTR) saw its price target double to $80 from $41 by Goldman Sachs analyst ...
Despite the turmoil that has gripped the U.S. tech sector over the weekend leading into January 27, analysts remain bullish ...
Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...
As of 10:50 a.m. ET, the stock was down by 3.2% ... This in turn implies that Target's prices may be too high. That could spur the company to further discount its wares, which would hurt profit ...
Analyst Ross Fowler downgraded American States Water from Neutral to Underperform, reducing its price target from $85 to $71.
As was the case with AES, CVS Health's share price has plunged almost 60% below its high. But Wall Street likes this stock going forward. The average 12-month price target is 41% above CVS ...
And this, in a nutshell, is why investors are selling Target stock. Target's guidance update ... This in turn implies that Target's prices may be too high. That could spur the company to further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results